US STOCKS-Wall St inches lower with healthcare shares
* Retail sales top expectations
* Biotech stocks lose ground
* Indexes: Dow off 0.2 pct, S&P down 0.2 pct, Nasdaq down 0.1 pct (Updates to afternoon)
By Caroline Valetkevitch
NEW YORK, Nov 14 (Reuters) - U.S. stocks edged lower on Friday afternoon, led by losses in healthcare shares.
Biotech stocks were among the biggest decliners in the S&P health care index, which fell 1.1 percent. Gilead was down 2.5 percent and Biogen Idec lost 4.2 percent.
Helping to limit losses was a stronger-than-expected rise in October retail sales.
"Oil prices moving lower would be a net benefit from most people's perspectives because it frees up so much potential disposable spending on the part of the U.S. consumer," said Peter Kenny, chief market strategist at Clearpool Group in New York.
At 2:07 p.m., the Dow Jones industrial average fell 38.31 points, or 0.22 percent, to 17,614.48, the S&P 500 lost 3.98 points, or 0.2 percent, to 2,035.35 and the Nasdaq Composite dropped 5.61 points, or 0.12 percent, to 4,674.53. Continuación...